Disease Overview：Congenital Adrenal Hyperplasia（CAH）
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders caused by enzymatic defects in cortisol biosynthesis, most commonly due to 21-hydroxylase deficiency. This leads to impaired glucocorticoid and mineralocorticoid production, with compensatory adrenocorticotropic hormone (ACTH) elevation resulting in adrenal hyperplasia and excess androgen synthesis. Clinical manifestations vary by severity—classic forms present neonatally with salt-wasting crises or ambiguous genitalia in females, while non-classic CAH may manifest later with hirsutism, oligomenorrhea, infertility, or precocious puberty. Accurate diagnosis relies on hormonal profiling (e.g., elevated 17-hydroxyprogesterone), genetic testing, and imaging when indicated. Long-term management involves lifelong glucocorticoid replacement, mineralocorticoid supplementation if needed, and multidisciplinary care—including endocrinology, reproductive medicine, and pediatric or adult urology—to address fertility, metabolic health, and psychosocial well-being.
China offers distinct advantages for CAH management: leading academic hospitals house nationally certified endocrine and reproductive medicine centers with extensive experience in complex adrenal disorders and fertility preservation. Advanced diagnostics—including tandem mass spectrometry for steroid profiling and next-generation sequencing for genotype-phenotype correlation—are widely available. Success rates in restoring ovulatory cycles, supporting assisted reproductive technologies (ART), and achieving live births in women with non-classic CAH match international benchmarks. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising clinical rigor or regulatory oversight. As a dedicated medical tourism agency, we facilitate seamless access for international patients—coordinating appointments with CAH-specialized teams, providing itemized, transparent pricing, arranging interpreters and accommodation, and offering continuous support from initial consultation through follow-up care.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Congenital Adrenal Hyperplasia (CAH) — Reproductive Medicine Department
Non-Surgical / Conservative Management
*Target Criteria:* All classic and non-classic CAH patients requiring lifelong glucocorticoid/mineralocorticoid replacement, adrenal crisis prevention, and fertility optimization.
- •Baseline Diagnostic Workup
- Pelvic/abdominal ultrasound (adrenal morphology, uterine anatomy, ovarian cysts): $45–$65 - Bone age X-ray (children/adolescents): $25–$35 - DHEA-S, testosterone (females), sperm analysis (males): $30–$50 each
- •Chronic Medication Therapy (Annual)
- Fludrocortisone (for salt-wasting forms): $90–$130 - Monitoring labs (quarterly 17-OHP, androstenedione, electrolytes, IGF-1): $320–$480/year - Endocrinology + reproductive medicine follow-up visits (4×/year): $240–$360/year
Surgical / Procedural Interventions
*Eligibility Criteria:* Females with Prader III–V virilization requiring feminizing genitoplasty; males with testicular adrenal rest tumors (TARTs) causing obstruction or infertility.
- •Feminizing Genitoplasty (Clitoroplasty + Vaginoplasty)
- Surgery (single-stage, Grade 3A hospital, 3–5 days admission): $4,200–$6,100 - Post-op hormonal stabilization & gynecologic follow-up (6 months): $210–$320
- •Testicular Adrenal Rest Tumor (TART) Resection or Embolization
- Laparoscopic or open tumor resection (if obstructive/infertility-related): $3,400–$5,000 - Selective arterial embolization (for multifocal/unresectable TARTs): $4,800–$6,700
Special / Complex Condition Management
- •Adrenal Crisis Hospitalization (ICU admission, IV hydrocortisone, fluid resuscitation, monitoring): $2,100–$3,900/day (avg. 3–5 days)
- •Fertility Preservation & Assisted Reproduction
- Sperm retrieval (micro-TESE) + ICSI (for males with TART-related azoospermia): $5,300–$7,200/cycle
- •Growth Hormone Adjunct Therapy (for severe short stature despite optimal CAH control): $1,900–$2,700/month
Quick Selection Guide
- •Infants (<1 yr) with salt-wasting CAH: Prioritize urgent hydrocortisone + fludrocortisone initiation + baseline labs ($320 initial setup); defer surgery until age 6–12 mo if indicated.
- •Adolescent females with Prader IV–V virilization & fertility concerns: Genitoplasty + concurrent fertility counseling ($4,800–$6,500 total first-year cost) — optimal before menarche.
- •Adult males with TARTs + oligospermia: MRI + micro-TESE/ICSI pathway ($7,500–$9,900) preferred over unilateral orchidectomy.
- •Budget-constrained patients (<$1,000/year): Generic hydrocortisone + quarterly 17-OHP monitoring only ($520–$720/year) — acceptable for stable non-salt-wasting non-classic CAH.
- •Comorbid obesity/diabetes: Add annual HbA1c, liver ultrasound, and endocrine-dietitian consult (+$180–$260/year) to mitigate metabolic complications.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Congenital Adrenal Hyperplasia Medical Vacation Packages
Curated transparent all-inclusive packages combining Congenital Adrenal Hyperplasia treatment with China top medical destinations:
